theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Thoracic Surgery

ASCO Journal Club   

Journal Club Q&A done in partnership with ASCO the Journal of Clinical Oncology

Questions discussed in this category


Is there any role for ctDNA testing after surgery or SBRT for Stage IB NSCLC to determine the need for adjuvant chemotherapy?
1 Answer available
2597


Papers discussed in this category


JCO Precision Oncology, 2017 Sep 29
Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician

Nature, 2017-04-26
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Cancer discovery, 2017-12
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Related Topics in Thoracic Surgery

  • Thoracic Malignancies
  • Radiation Oncology
  • Medical Oncology
  • Non-small cell lung cancer
  • Lung Cancer
  • General Internal Medicine
  • NCI-CCC Tumor Board Question
  • Pulmonology
  • Hospital Medicine
  • Pleural Effusion

Copyright © 2025 theMednet
All Rights Reserved.